Stem cells educator therapy in clinical trials of patients with T1D and T2D has had some positive results in improving metabolic control, restoration of islet beta cell function or islet beta cell regeneration, reversing autoimmunity, and improving insulin sensitivity (218, 221, 223–225). This evidence concerns the gene INS and type 2 diabetes mellitus.